Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis [0.03%]
心理测验、闪烁频率和炎症指标在隐匿性肝性脑病诊断中的作用
Erkut Demirciler,Nilay Danis,Pelin Ergun et al.
Erkut Demirciler et al.
Background and aim: Hepatic encephalopathy (HE) is a frequent complication of liver diseases. Systemic inflammation is key for HE pathogenesis. The main goal of the study was to investigate the role of psychometric tests,...
Can first-trimester aspartate aminotransferase/platelet ratio index score predict intrahepatic cholestasis of pregnancy? [0.03%]
第一孕期天冬氨酸氨基转移酶血小板比率指数评分能否预测妊娠期肝内胆汁淤积症？
Koray Gok,Taha Takmaz,Osman Kose et al.
Koray Gok et al.
Background and aim: The study aimed to investigate the effectiveness of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet values in predicting intrahepatic cholestasis of pregnancy (ICP) in th...
Rare association of solitary necrotic nodule of the liver with rheumatoid arthritis and systemic lupus erythematosus [0.03%]
孤立性肝坏死结节与类风湿关节炎和系统性红斑狼疮并发的罕见病例报告
Nil Kocanali,Fevzi Duhan Berkan Kilickan,Hale Kirimlioglu et al.
Nil Kocanali et al.
Solitary necrotic nodule of the liver (SNNL) is a rare benign lesion with uncertain etiology characterized by a "completely necrotic core" and a hyalinized capsule containing elastin fibers (Journal of Clinical Pathology 36:1181-1183, 1983)...
Case Reports
Hepatology forum. 2023 Jan 17;4(1):37-39. DOI:10.14744/hf.2022.2022.0020 2023
Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye [0.03%]
与酒精相关的医社保问题和肝病：土耳其酒精性肝硬化和肝细胞癌的疾病负担
Yilmaz Cakaloglu
Yilmaz Cakaloglu
The World Health Organization 2018 report stated that 2.3 billion persons over 15 years old consume alcohol, and a total of 3.0-3.3 million people died because of uncontrolled or harmful alcohol intake in 2016. Injuries, accidents, liver ci...
Evaluation of fibrosis with noninvasive biochemical tests in chronic viral hepatitis B [0.03%]
慢性乙型病毒性肝炎患者血清学检测评估肝纤维化程度的研究
Adem Kaya,Sezgin Barutcu,Murat Taner Gulsen
Adem Kaya
Background and aim: Early diagnosis and treatment of chronic hepatitis B (CHB) disease are important for the prevention of complications such as cirrhosis and hepatocellular cancer. Liver biopsy is an invasive, complicate...
Dilara Turan Gokce,Derya Ari,Hale Gokcan et al.
Dilara Turan Gokce et al.
Hepatoportal sclerosis (HPS) is an idiopathic non-cirrhotic portal hypertension (INCPH) characterized by hypersplenism, portal hypertension, and splenomegaly. Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Non-cirrh...
Case Reports
Hepatology forum. 2023 Jan 17;4(1):35-36. DOI:10.14744/hf.2022.2022.0018 2023
Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective [0.03%]
低剂量乙肝免疫球蛋白在肝移植中预防作用的单中心观点分析
Diep Edwards,Jessica Lin,Lindsey Toman et al.
Diep Edwards et al.
Background and aim: Prevention of hepatitis B virus (HBV) reinfection is important for long-term outcomes following liver transplantation (LT). Hepatitis B immunoglobulin (HBIG) is used among recipients who have (i) nativ...
Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease [0.03%]
转诊至纤维扫描中心的慢性肝病病因变化：非酒精性脂肪肝病患病率增加
Tansu Eris,Moomen Hassan,Yousra Hikal et al.
Tansu Eris et al.
Background and aim: Chronic liver disease (CLD) is a leading cause of morbidity and mortality worldwide with a wide etiological spectrum. FibroScan® is used for follow-up of fibrosis and steatosis. This single-center stu...
The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease [0.03%]
磁共振弹性成像技术在非酒精性脂肪肝病评估中的作用
Ilkay S Idilman,Musturay Karcaaltincaba
Ilkay S Idilman
Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan [0.03%]
基于FibroScan的肾脏移植受者的代谢紊乱相关脂肪性肝病横断面研究及其危险因素分析
Ezgi Ersoy Yesil,Yusuf Yilmaz,Atakan Yesil et al.
Ezgi Ersoy Yesil et al.
Background and aim: Metabolic dysfunction-associated fatty liver disease (MAFLD) is expected to be prevalent among kidney transplant recipients (KTRs). In this study, we evaluated the prevalence of MAFLD among KTRs, data ...